401k Plan data: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN plan

CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 401k Plan overview

Plan Name	CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN
Plan identification number	001

CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. has sponsored the creation of one or more 401k plans.

Company Name: ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.

Employer identification number (EIN): 541716562

NAIC Classification: 621510
NAIC Description: Medical and Diagnostic Laboratories

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01 RYAN LEWIS 2019-10-03
001 2017-01-01
001 2016-01-01 JACQUELYN BOVINET
001 2015-01-01 VICTORIA TIFFT
001 2014-01-01 VICTORIA TIFFT
001 2013-01-01 VICTORIA TIFFT
001 2012-01-01 VICTORIA TIFFT
001 2011-01-01 VICTORIA TIFFT
001 2010-01-01 VICTORIA TIFFT
001 2009-01-01 QUINTEN TIFFT
001 2009-01-01 QUINTEN TIFFT

Plan Statistics for CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN

401k plan membership statisitcs for CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN

Measure Date Value
2022: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 453
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 0
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 0
Total of all active and inactive participants 2022-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 0
Number of participants with account balances 2022-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 442
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 143
Number of retired or separated participants receiving benefits 2021-01-01 2
Number of other retired or separated participants entitled to future benefits 2021-01-01 307
Total of all active and inactive participants 2021-01-01 452
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 1
Total participants 2021-01-01 453
Number of participants with account balances 2021-01-01 453
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 56
2020: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 456
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 204
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 238
Total of all active and inactive participants 2020-01-01 442
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 442
Number of participants with account balances 2020-01-01 442
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 44
2019: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 458
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 180
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 276
Total of all active and inactive participants 2019-01-01 456
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 456
Number of participants with account balances 2019-01-01 456
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 36
2018: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 563
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 203
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 255
Total of all active and inactive participants 2018-01-01 458
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 458
Number of participants with account balances 2018-01-01 458
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 60
2017: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 598
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 343
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 220
Total of all active and inactive participants 2017-01-01 563
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 563
Number of participants with account balances 2017-01-01 492
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 75
2016: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 563
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 493
Number of retired or separated participants receiving benefits 2016-01-01 48
Number of other retired or separated participants entitled to future benefits 2016-01-01 57
Total of all active and inactive participants 2016-01-01 598
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 598
Number of participants with account balances 2016-01-01 487
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 25
2015: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 476
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 450
Number of retired or separated participants receiving benefits 2015-01-01 2
Number of other retired or separated participants entitled to future benefits 2015-01-01 109
Total of all active and inactive participants 2015-01-01 561
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 561
Number of participants with account balances 2015-01-01 482
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 31
2014: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 493
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 394
Number of retired or separated participants receiving benefits 2014-01-01 2
Number of other retired or separated participants entitled to future benefits 2014-01-01 122
Total of all active and inactive participants 2014-01-01 518
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 518
Number of participants with account balances 2014-01-01 446
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 37
2013: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 545
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 369
Number of retired or separated participants receiving benefits 2013-01-01 1
Number of other retired or separated participants entitled to future benefits 2013-01-01 123
Total of all active and inactive participants 2013-01-01 493
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 493
Number of participants with account balances 2013-01-01 427
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 33
2012: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 468
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 364
Number of retired or separated participants receiving benefits 2012-01-01 4
Number of other retired or separated participants entitled to future benefits 2012-01-01 177
Total of all active and inactive participants 2012-01-01 545
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 545
Number of participants with account balances 2012-01-01 471
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 50
2011: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 453
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 330
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 138
Total of all active and inactive participants 2011-01-01 468
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 468
Number of participants with account balances 2011-01-01 420
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 28
2010: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 444
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 316
Number of retired or separated participants receiving benefits 2010-01-01 1
Number of other retired or separated participants entitled to future benefits 2010-01-01 136
Total of all active and inactive participants 2010-01-01 453
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 453
Number of participants with account balances 2010-01-01 401
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 24
2009: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 311
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 300
Number of retired or separated participants receiving benefits 2009-01-01 18
Number of other retired or separated participants entitled to future benefits 2009-01-01 126
Total of all active and inactive participants 2009-01-01 444
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 444
Number of participants with account balances 2009-01-01 399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 29

Measure	Date	Value
2022: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	453
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	0
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	0
Total of all active and inactive participants	2022-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	0
Number of participants with account balances	2022-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	442
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	143
Number of retired or separated participants receiving benefits	2021-01-01	2
Number of other retired or separated participants entitled to future benefits	2021-01-01	307
Total of all active and inactive participants	2021-01-01	452
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	1
Total participants	2021-01-01	453
Number of participants with account balances	2021-01-01	453
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	56
2020: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	456
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	204
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	238
Total of all active and inactive participants	2020-01-01	442
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	442
Number of participants with account balances	2020-01-01	442
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	44
2019: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	458
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	180
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	276
Total of all active and inactive participants	2019-01-01	456
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	456
Number of participants with account balances	2019-01-01	456
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	36
2018: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	563
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	203
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	255
Total of all active and inactive participants	2018-01-01	458
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	458
Number of participants with account balances	2018-01-01	458
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	60
2017: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	598
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	343
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	220
Total of all active and inactive participants	2017-01-01	563
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	563
Number of participants with account balances	2017-01-01	492
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	75
2016: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	563
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	493
Number of retired or separated participants receiving benefits	2016-01-01	48
Number of other retired or separated participants entitled to future benefits	2016-01-01	57
Total of all active and inactive participants	2016-01-01	598
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	598
Number of participants with account balances	2016-01-01	487
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	25
2015: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	476
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	450
Number of retired or separated participants receiving benefits	2015-01-01	2
Number of other retired or separated participants entitled to future benefits	2015-01-01	109
Total of all active and inactive participants	2015-01-01	561
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	561
Number of participants with account balances	2015-01-01	482
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	31
2014: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	493
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	394
Number of retired or separated participants receiving benefits	2014-01-01	2
Number of other retired or separated participants entitled to future benefits	2014-01-01	122
Total of all active and inactive participants	2014-01-01	518
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	518
Number of participants with account balances	2014-01-01	446
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	37
2013: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	545
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	369
Number of retired or separated participants receiving benefits	2013-01-01	1
Number of other retired or separated participants entitled to future benefits	2013-01-01	123
Total of all active and inactive participants	2013-01-01	493
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	493
Number of participants with account balances	2013-01-01	427
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	33
2012: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	468
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	364
Number of retired or separated participants receiving benefits	2012-01-01	4
Number of other retired or separated participants entitled to future benefits	2012-01-01	177
Total of all active and inactive participants	2012-01-01	545
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	545
Number of participants with account balances	2012-01-01	471
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	50
2011: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	453
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	330
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	138
Total of all active and inactive participants	2011-01-01	468
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	468
Number of participants with account balances	2011-01-01	420
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	28
2010: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	444
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	316
Number of retired or separated participants receiving benefits	2010-01-01	1
Number of other retired or separated participants entitled to future benefits	2010-01-01	136
Total of all active and inactive participants	2010-01-01	453
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	453
Number of participants with account balances	2010-01-01	401
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	24
2009: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	311
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	300
Number of retired or separated participants receiving benefits	2009-01-01	18
Number of other retired or separated participants entitled to future benefits	2009-01-01	126
Total of all active and inactive participants	2009-01-01	444
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	444
Number of participants with account balances	2009-01-01	399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	29

Financial Data on CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN

Measure	Date	Value
2022 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2022 401k financial data
Total transfer of assets from this plan	2022-12-31	$20,326,482
Total income from all sources (including contributions)	2022-12-31	$-3,716,521
Total of all expenses incurred	2022-12-31	$6,946,887
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$6,903,742
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,706,861
Value of total assets at end of year	2022-12-31	$0
Value of total assets at beginning of year	2022-12-31	$30,989,890
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$43,145
Total interest from all sources	2022-12-31	$5,389
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$78,620
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2022-12-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$78,620
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$1,199,103
Participant contributions at end of year	2022-12-31	$0
Participant contributions at beginning of year	2022-12-31	$88,373
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$281,149
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$61
Administrative expenses (other) incurred	2022-12-31	$19,849
Total non interest bearing cash at end of year	2022-12-31	$0
Total non interest bearing cash at beginning of year	2022-12-31	$14,392
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-10,663,408
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$0
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$30,989,890
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$23,296
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$7,207,790
Interest on participant loans	2022-12-31	$5,177
Value of interest in common/collective trusts at end of year	2022-12-31	$0
Value of interest in common/collective trusts at beginning of year	2022-12-31	$23,619,475
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$59,799
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$59,799
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$212
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-1,693,235
Net investment gain or loss from common/collective trusts	2022-12-31	$-3,814,156
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$226,609
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$6,903,742
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2022-12-31	No
Did the plan have assets held for investment	2022-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2022-12-31	341523030
2021 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$6,886,943
Total of all expenses incurred	2021-12-31	$4,799,815
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$4,734,422
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$2,818,506
Value of total assets at end of year	2021-12-31	$30,989,890
Value of total assets at beginning of year	2021-12-31	$28,902,762
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$65,393
Total interest from all sources	2021-12-31	$6,510
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$126,392
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$126,392
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,242,475
Participant contributions at end of year	2021-12-31	$88,373
Participant contributions at beginning of year	2021-12-31	$129,400
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$228,506
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$61
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$189
Administrative expenses (other) incurred	2021-12-31	$20,807
Total non interest bearing cash at end of year	2021-12-31	$14,392
Total non interest bearing cash at beginning of year	2021-12-31	$13,073
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$2,087,128
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$30,989,890
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$28,902,762
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$44,586
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$7,207,790
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$5,330,506
Interest on participant loans	2021-12-31	$6,510
Value of interest in common/collective trusts at end of year	2021-12-31	$23,619,475
Value of interest in common/collective trusts at beginning of year	2021-12-31	$23,426,690
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$59,799
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$2,904
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$2,904
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$922,452
Net investment gain or loss from common/collective trusts	2021-12-31	$3,013,083
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$347,525
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$4,734,422
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-12-31	No
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2021-12-31	341523030
2020 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$6,007,850
Total of all expenses incurred	2020-12-31	$3,193,407
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$3,131,357
Expenses. Certain deemed distributions of participant loans	2020-12-31	$3,746
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$2,101,195
Value of total assets at end of year	2020-12-31	$28,902,762
Value of total assets at beginning of year	2020-12-31	$26,088,319
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$58,304
Total interest from all sources	2020-12-31	$8,250
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$72,257
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$72,257
Administrative expenses professional fees incurred	2020-12-31	$5,500
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,598,015
Participant contributions at end of year	2020-12-31	$129,400
Participant contributions at beginning of year	2020-12-31	$152,392
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$180,694
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$189
Administrative expenses (other) incurred	2020-12-31	$16,696
Total non interest bearing cash at end of year	2020-12-31	$13,073
Total non interest bearing cash at beginning of year	2020-12-31	$6,549
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,814,443
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$28,902,762
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$26,088,319
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$36,108
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$5,330,506
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$4,347,073
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$0
Interest on participant loans	2020-12-31	$8,212
Value of interest in common/collective trusts at end of year	2020-12-31	$23,426,690
Value of interest in common/collective trusts at beginning of year	2020-12-31	$21,563,329
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$2,904
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$18,976
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$18,976
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$38
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$867,145
Net investment gain or loss from common/collective trusts	2020-12-31	$2,959,003
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$322,486
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$3,131,357
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	No
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2020-12-31	341523030
2019 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$6,813,000
Total of all expenses incurred	2019-12-31	$3,064,289
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$2,999,132
Value of total corrective distributions	2019-12-31	$10,910
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,697,763
Value of total assets at end of year	2019-12-31	$26,088,319
Value of total assets at beginning of year	2019-12-31	$22,339,608
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$54,247
Total interest from all sources	2019-12-31	$11,658
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$65,558
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$65,558
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,822,171
Participant contributions at end of year	2019-12-31	$152,392
Participant contributions at beginning of year	2019-12-31	$164,536
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$376,200
Administrative expenses (other) incurred	2019-12-31	$27,265
Total non interest bearing cash at end of year	2019-12-31	$6,549
Total non interest bearing cash at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$3,748,711
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$26,088,319
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$22,339,608
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$26,982
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$4,347,073
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$0
Value of interest in pooled separate accounts at end of year	2019-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$22,175,072
Interest on participant loans	2019-12-31	$10,173
Value of interest in common/collective trusts at end of year	2019-12-31	$21,563,329
Value of interest in common/collective trusts at beginning of year	2019-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$18,976
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$1,485
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$628,178
Net investment gain or loss from common/collective trusts	2019-12-31	$3,409,843
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$499,392
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$2,999,132
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2019-12-31	341523030
2018 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,148,143
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$4,645,789
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$4,555,813
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,791,934
Value of total assets at end of year	2018-12-31	$22,339,608
Value of total assets at beginning of year	2018-12-31	$25,837,254
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$89,976
Total interest from all sources	2018-12-31	$11,995
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$2,072,711
Participant contributions at end of year	2018-12-31	$164,536
Participant contributions at beginning of year	2018-12-31	$262,152
Assets. Other investments not covered elsewhere at end of year	2018-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2018-12-31	$41,480
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$203,026
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-3,497,646
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$22,339,608
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$25,837,254
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$89,976
Value of interest in pooled separate accounts at end of year	2018-12-31	$22,175,072
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$25,491,620
Interest on participant loans	2018-12-31	$11,788
Interest earned on other investments	2018-12-31	$207
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$42,002
Net investment gain/loss from pooled separate accounts	2018-12-31	$-1,655,786
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$516,197
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$4,555,813
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2018-12-31	341523030
2017 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$7,178,435
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$3,912,551
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$3,907,208
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$3,344,984
Value of total assets at end of year	2017-12-31	$25,837,254
Value of total assets at beginning of year	2017-12-31	$22,571,370
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$5,343
Total interest from all sources	2017-12-31	$17,955
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Administrative expenses professional fees incurred	2017-12-31	$5,343
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$2,449,619
Participant contributions at end of year	2017-12-31	$262,152
Participant contributions at beginning of year	2017-12-31	$347,529
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$41,480
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$19,470
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$109,621
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$3,265,884
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$25,837,254
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$22,571,370
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in pooled separate accounts at end of year	2017-12-31	$25,491,620
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$22,168,384
Interest on participant loans	2017-12-31	$17,683
Interest earned on other investments	2017-12-31	$272
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$42,002
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$35,987
Net investment gain/loss from pooled separate accounts	2017-12-31	$3,815,496
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$785,744
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$3,907,208
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2017-12-31	341523030
2016 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2016 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2016-12-31	$127
Total unrealized appreciation/depreciation of assets	2016-12-31	$127
Expenses. Interest paid	2016-12-31	$338
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2016-12-31	$338
Total income from all sources (including contributions)	2016-12-31	$5,839,422
Total of all expenses incurred	2016-12-31	$3,609,834
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$3,580,002
Expenses. Certain deemed distributions of participant loans	2016-12-31	$22,774
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$4,203,281
Value of total assets at end of year	2016-12-31	$22,571,370
Value of total assets at beginning of year	2016-12-31	$20,341,782
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$6,720
Total interest from all sources	2016-12-31	$15,076
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Administrative expenses professional fees incurred	2016-12-31	$6,720
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$2,817,019
Participant contributions at end of year	2016-12-31	$347,529
Participant contributions at beginning of year	2016-12-31	$177,748
Assets. Other investments not covered elsewhere at end of year	2016-12-31	$19,470
Assets. Other investments not covered elsewhere at beginning of year	2016-12-31	$100,473
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$621,135
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$2,229,588
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$22,571,370
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$20,341,782
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in pooled separate accounts at end of year	2016-12-31	$22,168,384
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$19,996,037
Interest on participant loans	2016-12-31	$14,864
Interest earned on other investments	2016-12-31	$212
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$35,987
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$67,524
Net investment gain/loss from pooled separate accounts	2016-12-31	$1,620,938
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$765,127
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$3,580,002
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2016-12-31	341523030
2015 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2015 401k financial data
Total income from all sources (including contributions)	2015-12-31	$3,995,033
Total of all expenses incurred	2015-12-31	$2,868,092
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$2,760,122
Expenses. Certain deemed distributions of participant loans	2015-12-31	$101,701
Value of total corrective distributions	2015-12-31	$340
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$4,315,341
Value of total assets at end of year	2015-12-31	$20,341,782
Value of total assets at beginning of year	2015-12-31	$19,214,841
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$5,929
Total interest from all sources	2015-12-31	$10,244
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Administrative expenses professional fees incurred	2015-12-31	$5,929
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$2,516,038
Participant contributions at end of year	2015-12-31	$177,748
Participant contributions at beginning of year	2015-12-31	$202,604
Assets. Other investments not covered elsewhere at end of year	2015-12-31	$100,473
Assets. Other investments not covered elsewhere at beginning of year	2015-12-31	$69,303
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$1,098,272
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$1,126,941
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$20,341,782
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$19,214,841
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in pooled separate accounts at end of year	2015-12-31	$19,996,037
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$18,877,785
Interest on participant loans	2015-12-31	$10,176
Interest earned on other investments	2015-12-31	$68
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$67,524
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$65,149
Net investment gain/loss from pooled separate accounts	2015-12-31	$-330,552
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$701,031
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$2,760,122
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2015-12-31	341523030
2014 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2014 401k financial data
Total income from all sources (including contributions)	2014-12-31	$3,853,895
Total of all expenses incurred	2014-12-31	$1,585,526
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$1,542,842
Expenses. Certain deemed distributions of participant loans	2014-12-31	$33,437
Value of total corrective distributions	2014-12-31	$3,891
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$2,968,389
Value of total assets at end of year	2014-12-31	$19,214,841
Value of total assets at beginning of year	2014-12-31	$16,946,472
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$5,356
Total interest from all sources	2014-12-31	$8,917
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Administrative expenses professional fees incurred	2014-12-31	$4,720
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$2,008,572
Participant contributions at end of year	2014-12-31	$202,604
Participant contributions at beginning of year	2014-12-31	$93,568
Assets. Other investments not covered elsewhere at end of year	2014-12-31	$69,303
Assets. Other investments not covered elsewhere at beginning of year	2014-12-31	$27,867
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$344,776
Other income not declared elsewhere	2014-12-31	$627
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$2,268,369
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$19,214,841
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$16,946,472
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in pooled separate accounts at end of year	2014-12-31	$18,877,785
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$16,798,495
Interest on participant loans	2014-12-31	$8,881
Interest earned on other investments	2014-12-31	$36
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$65,149
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$26,542
Net investment gain/loss from pooled separate accounts	2014-12-31	$875,962
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$615,041
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$1,542,842
Contract administrator fees	2014-12-31	$636
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2014-12-31	341523030
2013 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2013 401k financial data
Total income from all sources (including contributions)	2013-12-31	$5,138,391
Total of all expenses incurred	2013-12-31	$1,865,748
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$1,850,037
Expenses. Certain deemed distributions of participant loans	2013-12-31	$8,383
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$2,536,329
Value of total assets at end of year	2013-12-31	$16,946,472
Value of total assets at beginning of year	2013-12-31	$13,673,829
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$7,328
Total interest from all sources	2013-12-31	$5,429
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Administrative expenses professional fees incurred	2013-12-31	$6,705
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$1,768,238
Participant contributions at end of year	2013-12-31	$93,568
Participant contributions at beginning of year	2013-12-31	$121,319
Assets. Other investments not covered elsewhere at end of year	2013-12-31	$27,867
Assets. Other investments not covered elsewhere at beginning of year	2013-12-31	$42,005
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$255,929
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$3,272,643
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$16,946,472
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$13,673,829
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Investment advisory and management fees	2013-12-31	$21
Value of interest in pooled separate accounts at end of year	2013-12-31	$16,798,495
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$13,504,940
Interest on participant loans	2013-12-31	$5,421
Interest earned on other investments	2013-12-31	$8
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$26,542
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$4,247
Net investment gain/loss from pooled separate accounts	2013-12-31	$2,596,633
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$512,162
Employer contributions (assets) at beginning of year	2013-12-31	$1,318
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$1,850,037
Contract administrator fees	2013-12-31	$602
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2013-12-31	341523030
2012 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2012 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$4,264,449
Total of all expenses incurred	2012-12-31	$1,410,434
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$1,366,016
Expenses. Certain deemed distributions of participant loans	2012-12-31	$32,040
Value of total corrective distributions	2012-12-31	$8,457
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$2,781,472
Value of total assets at end of year	2012-12-31	$13,673,829
Value of total assets at beginning of year	2012-12-31	$10,819,814
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$3,921
Total interest from all sources	2012-12-31	$9,026
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Administrative expenses professional fees incurred	2012-12-31	$3,225
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$1,554,291
Participant contributions at end of year	2012-12-31	$121,319
Participant contributions at beginning of year	2012-12-31	$223,668
Participant contributions at beginning of year	2012-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2012-12-31	$42,005
Assets. Other investments not covered elsewhere at beginning of year	2012-12-31	$26,515
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$784,623
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2012-12-31	$0
Administrative expenses (other) incurred	2012-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$2,854,015
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$13,673,829
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$10,819,814
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Investment advisory and management fees	2012-12-31	$0
Value of interest in pooled separate accounts at end of year	2012-12-31	$13,504,940
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$10,568,180
Interest on participant loans	2012-12-31	$9,025
Interest earned on other investments	2012-12-31	$1
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$4,247
Net investment gain/loss from pooled separate accounts	2012-12-31	$1,473,951
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$442,558
Employer contributions (assets) at end of year	2012-12-31	$1,318
Employer contributions (assets) at beginning of year	2012-12-31	$1,451
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$1,366,016
Contract administrator fees	2012-12-31	$696
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	BOBER MARKEY FEDOROVICH & CO
Accountancy firm EIN	2012-12-31	341523030
2011 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$1,736,210
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$934,786
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$923,850
Expenses. Certain deemed distributions of participant loans	2011-12-31	$6,429
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$2,160,077
Value of total assets at end of year	2011-12-31	$10,819,814
Value of total assets at beginning of year	2011-12-31	$10,018,390
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$4,507
Total interest from all sources	2011-12-31	$9,150
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Administrative expenses professional fees incurred	2011-12-31	$3,860
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$1,445,689
Participant contributions at end of year	2011-12-31	$223,668
Participant contributions at beginning of year	2011-12-31	$107,613
Participant contributions at end of year	2011-12-31	$0
Participant contributions at beginning of year	2011-12-31	$311
Assets. Other investments not covered elsewhere at end of year	2011-12-31	$26,515
Assets. Other investments not covered elsewhere at beginning of year	2011-12-31	$36,747
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$262,814
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2011-12-31	$37,436
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2011-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2011-12-31	$0
Administrative expenses (other) incurred	2011-12-31	$5
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$801,424
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$10,819,814
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$10,018,390
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in pooled separate accounts at end of year	2011-12-31	$10,568,180
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$9,873,719
Interest on participant loans	2011-12-31	$9,150
Net investment gain/loss from pooled separate accounts	2011-12-31	$-433,017
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$451,574
Employer contributions (assets) at end of year	2011-12-31	$1,451
Employer contributions (assets) at beginning of year	2011-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$886,414
Contract administrator fees	2011-12-31	$642
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	BOBER MARKEY FEDOROVICH & CO.
Accountancy firm EIN	2011-12-31	341523030
2010 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$3,137,036
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$841,255
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$828,412
Expenses. Certain deemed distributions of participant loans	2010-12-31	$6,294
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$2,004,855
Value of total assets at end of year	2010-12-31	$10,018,390
Value of total assets at beginning of year	2010-12-31	$7,722,609
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$6,549
Total interest from all sources	2010-12-31	$5,371
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Administrative expenses professional fees incurred	2010-12-31	$4,119
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$1,470,961
Participant contributions at end of year	2010-12-31	$107,613
Participant contributions at beginning of year	2010-12-31	$55,484
Participant contributions at end of year	2010-12-31	$311
Participant contributions at beginning of year	2010-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2010-12-31	$36,747
Assets. Other investments not covered elsewhere at beginning of year	2010-12-31	$38,886
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$87,896
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2010-12-31	$39,575
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2010-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$0
Administrative expenses (other) incurred	2010-12-31	$2,430
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$2,295,781
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$10,018,390
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$7,722,609
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in pooled separate accounts at end of year	2010-12-31	$9,873,719
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$7,628,239
Interest on participant loans	2010-12-31	$5,371
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2010-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2010-12-31	$0
Net investment gain/loss from pooled separate accounts	2010-12-31	$1,126,810
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$445,998
Employer contributions (assets) at end of year	2010-12-31	$0
Employer contributions (assets) at beginning of year	2010-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$788,837
Contract administrator fees	2010-12-31	$0
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	BOBER MARKEY FEDOROVICH & CO.
Accountancy firm EIN	2010-12-31	341523030
2009 : CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN

2022: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Insurance	Yes
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement – Insurance	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Insurance	Yes
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement – Insurance	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: CLINICAL RESEARCH MANAGEMENT, INC. 401(K)SALARY REDUCTION PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	Yes
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement – Insurance	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	0
Insurance policy start date	2019-01-01
Insurance policy end date	2019-01-01
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	468
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $18,580
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $18,580
Amount paid for insurance broker fees	0
Additional information about fees paid to insurance broker	ADMINISTRATION
Insurance broker organization code?	5

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	498
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Total amount of commissions paid to insurance broker	USD $14,266
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $9,416
Amount paid for insurance broker fees	0
Additional information about fees paid to insurance broker	ADMINISTRATION
Insurance broker organization code?	5
Insurance broker name	QUALIFIED PENSION CONSULTANTS, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	486
Insurance policy start date	2015-01-01
Insurance policy end date	2015-12-31
Total amount of fees paid to insurance company	USD $49,087
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	5350
Insurance broker organization code?	5
Insurance broker name	PARADIGM INVESTMENT ADVISORS

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	452
Insurance policy start date	2014-01-01
Insurance policy end date	2014-12-31
Total amount of fees paid to insurance company	USD $44,641
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	5432
Additional information about fees paid to insurance broker	FEES
Insurance broker organization code?	5
Insurance broker name	PARADIGM INVESTMENT ADVISORS

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	433
Insurance policy start date	2013-01-01
Insurance policy end date	2013-12-31
Total amount of commissions paid to insurance broker	USD $32,089
Total amount of fees paid to insurance company	USD $6,750
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	6750
Insurance broker organization code?	5
Commission paid to Insurance Broker	USD $32,089
Insurance broker name	SAFEGUARD SECURITIES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	478
Insurance policy start date	2012-01-01
Insurance policy end date	2012-12-31
Total amount of commissions paid to insurance broker	USD $32,323
Total amount of fees paid to insurance company	USD $3,240
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	3240
Additional information about fees paid to insurance broker	TPA FEES
Insurance broker organization code?	5
Commission paid to Insurance Broker	USD $32,323
Insurance broker name	SAFEGUARD SECURITIES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	426
Insurance policy start date	2011-01-01
Insurance policy end date	2011-12-31
Total amount of commissions paid to insurance broker	USD $29,643
Total amount of fees paid to insurance company	USD $3,970
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	Yes
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Other information about contract	PENSION GROUP ANNUITY CONTRACT

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

78566

Policy instance

Insurance contract or identification number	78566
Number of Individuals Covered	407
Insurance policy start date	2010-01-01
Insurance policy end date	2010-12-31
Total amount of commissions paid to insurance broker	USD $23,602
Total amount of fees paid to insurance company	USD $6,187
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	Yes
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Other information about contract	PENSION GROUP ANNUITY CONTRACT
Amount paid for insurance broker fees	3757
Additional information about fees paid to insurance broker	TPA FEES
Insurance broker organization code?	5
Commission paid to Insurance Broker	USD $23,602
Insurance broker name	VANGUARD GROUP, INC.

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
Employer identification number (EIN):	541716562
NAIC Classification:	621510
NAIC Description:	Medical and Diagnostic Laboratories